Objetivo. O objetivo do estudo foi analisar a influência da equoterapia sobre a função motora grossa em crianças com encefalopatia crônica não progressiva (ECNP) do tipo quadriparesia espástica. Método. Trata-se de uma série de casos com oito crianças com ECNP do tipo quadriparesia espástica. Foi realizada a identificação do desempenho funcional por meio da Gross Motor Function Clas¬sification System (GMFCS) e a avaliação da medida da função motora grossa por meio da Gross Motor Function Classification Measure (GMFM), antes e após as 40 sessões de equoterapia. As sessões foram realizadas uma vez por semana, durante 30 minutos, por um período de 10 meses. Resultados. Um participante do estudo foi classificado no nível III da classificação GMFCS, três no nível IV e quatro no nível V. O teste t de Student mostrou uma diferença nas pontuações obtidas nas dimensões A (deitar e rolar) e dimensão B (sentar) do GMFM, após o término das quarenta sessões de equoterapia. Conclusões. O tratamento equoterápico pode potencializar o desempenho funcional de crianças com ECNP do tipo quadriparesia espástica, possibilitando a evolução da sua função motora grossa, em especial as habilidade deitar/rolar e sentar
SUMMARY INTRODUCTION: Cancer patients and their caregivers incur costs not covered by the Sistema Único de Saúde – SUS(Unified Health System) during their treatment, with expenses related to transportation, symptomatic medications, food, loss of working days, and others. OBJECTIVE: To evaluate the costs incurred and not covered for cancer patients and their caregivers during cancer treatment at SUS. METHODS: This is a cross-sectional study of 110 cancer patients undergoing chemotherapy, radiotherapy, and 88 caregivers in the last month prior to their inclusion in the study. We correlated costs with clinical and sociodemographic variables such as gender, race, age, marital status, education, occupation, place of birth, origin, monthly income, family income, housing, comorbidities, types of cancer, and staging. RESULTS: We observed that the average cost for study patients was R$ 747.92, which corresponds to 78.4% of the minimum wage, and the average cost for caregivers was R$ 118.86, which is 12.46% of the minimum wage. Among all variables analyzed, the average overall monthly cost for patients was positively correlated with the occupation (p = 0.021) and origin (p = 0.038) variables. For the other variables, no significant associations were detected. CONCLUSION: The positive correlation found between occupation and origin variables with costs incurred and not covered for patients suggests that the creation of programs that enable the payment of costs not covered by SUS and the decentralization of access to cancer treatment could potentially facilitate patients' adherence to cancer treatment.
Cancer represents the second main cause of death worldwide, behind only cardiovascular diseases (CVD). 1 Projections for 2030 expect around 24 million cases of cancer and 14.6 million deaths. 2 This disease represents a global health challenge that has been increasing in low-and middle-income countries with the globalization of the economy and lifestyles. 3 Among various neoplasm types, breast cancer (BC) is the one that affects women the most each year, being responsible for 23% (1 380 000) of all new cancer cases and 14% (458 400) of all deaths due to cancer. 4 The number of long-term cancer survivors is increasing. A better organization of cancer care, more effective treatment options, and evidence-based tumor-specific protocols are factors that have contributed to this increase. [5][6][7] However, 2 out of 3 cancer survivors are prone to suffering from complications in the long term. 8 A wide spectrum of late adverse effects such as CVD, diabetes, dyslipidemia, arterial hypertension, osteoporosis, and metabolic syndrome (MS) components are likely to develop among cancer survivors. For this reason, it is important to design appropriate health management strategies for these patients. 7,[9][10]
O conteúdo dos artigos e seus dados em sua forma, correção e confiabilidade são de responsabilidade exclusiva dos autores.Permitido fazer download da obra e o compartilhamento desde que sejam atribuídos créditos aos autores, mas sem de nenhuma forma ou utilizá-la para fins comerciais.
Introduction: Cystic fibrosis (CF) is a genetic, systemic disorder characterized by generalized dysfunction of exocrine glands, with chronic progressive evolution. The Thoracic-Abdominal Rebalancing (TAR) aims to encourage ventilation and promote the removal of pulmonary secretions. Objective: To evaluate the influence of TAR on cardiorespiratory parameters in CF patients. Method: This is an exploratory retrospective study of case series, which involved eight patients with CF, of both sexes, aged 3-24 years, who underwent TAR. Records of information was extracted on the identification, age, gender, time of diagnosis and general clinical status, as well as the data of the cardiorespiratory parameters: Heart Rate (HR), Respiratory Rate (FR), blood pressure (BP) and Saturation peripheral oxygen (SpO2), before and after each service. To compare the values, we used the parametric Student t test for paired samples, with statistical significance level of p = 0.05. Results: Male gender was prevalent in 62.5% of the sample analyzed. The mean age was 12.12 ± 7.20 years. The median time to diagnosis was around 10.11 ± 5.48 years. Comparing the total average values, verified a decrease of BP and HR variables after the completion of the TAR. However, no statistically significant difference, since there was obtained, respectively, p = 0.097 / p = 0.062. However, the RR showed a significant decrease (p = 0.012) and SpO2 (p = 0.030), which showed an increase after the implementation of the method. Conclusion: The TAR may influence the cardiorespiratory variables in CF patients, is showing to be a safe technique and of great importance in the treatment of these patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.